Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Curcumin (high purity)

Inhibitor of Lipoxygenase and COX
ALX-350-028-M010 10 mg 44.00 USD
ALX-350-028-M050 50 mg 107.00 USD
ALX-350-028-M250 250 mg 383.00 USD
Do you need bulk/larger quantities?
Replaces Prod. #: BML-EI135

Dual inhibitor of 5-lipoxygenase (IC50=8µM) and cyclooxygenase (COX) (IC50=52µM). Also inhibits glutathione S-transferase, induction of nitric oxide (NO) in activated macrophages and inhibits EGF-induced tyrosine phosphorylation of EGF receptors. Antioxidant. Inhibitor of NAD(P)H:quinone oxidoreductase 1 (NQO1), disrupting the binding of NQO1 to wild type p53 inducing ubiquitin-independent degradation of p53 and inhibits p53-mediated apoptosis in normal thymocytes and myeloid leukemic cells. Has been shown to inhibit NF-κB, possibly through inhibition of JNK (IC50=10µM), the COP9 signalosome kinase (IC50=10µM) and p300/CBP.

Product Details

Alternative Name:1,7-bis(4-Hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione, Diferuloylmethane
Source:Isolated from turmeric (Curcuma longa).
MI:14: 2673
Purity:≥98% (HPLC)
Appearance:Orange-yellow crystalline powder.
Solubility:Soluble in acetic acid, 100% ethanol (at about 1mg/ml) or DMSO (25mg/ml).
Shipping:Ambient Temperature
Long Term Storage:Ambient
Handling:Protect from light.
Regulatory Status:RUO - Research Use Only
Please mouse over

Product Literature References

Combined Curcumin and Lansoprazole-Loaded Bioactive Solid Self-Nanoemulsifying Drug Delivery Systems (Bio-SSNEDDS): A. Alshaddi, et al.; Pharmaceutics 14, 2 (2022), Abstract;
Three-Dimensional Printing of a Container Tablet: A New Paradigm for Multi-Drug-Containing Bioactive Self-Nanoemulsifying Drug-Delivery Systems (Bio-SNEDDSs): V.R. Kulkarni, et al.; Pharmaceutics 14, 1082. (2022), Abstract;
Curcumin alleviates oxidative stress and mitochondrial dysfunction in astrocytes: A. Daverey, et al.; Neuroscience 333, 92 (2016), Application(s): Culture treatment, Abstract;
Curcumin Inhibits 3T3-L1 Preadipocyte Proliferation by Mechanisms Involving Post-transcriptional p27 Regulation: B.S. Ferguson, et al.; Biochem. Biophys. Rep. 5, 16 (2015), Application(s): Cell culture, Abstract; Full Text
Expression of Ceramide Synthase 6 Transcriptionally Activates Acid Ceramidase in a c-Jun N-Terminal Kinase (JNK)-Dependent Manner: T. S. Tirodkar, et al.; J. Biol. Chem. 290, 13157 (2015), Application(s): Cell Culture, Abstract; Full Text
Curcumin Extract for Prevention of Type 2 Diabetes: S. Chuengsamarn, et al.; Diabetes Care 35, 2121 (2012), Abstract;
Targeting pioneering factor and hormone receptor cooperative pathways to suppress tumor progression: S.A. Shah, et al.; Cancer Res. 72, 1248 (2012), Abstract;
The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats: T. Morimoto, et al.; J. Clin. Invest. 118, 868 (2008), Abstract; Full Text
Curcumin improves wound healing by modulating collagen and decreasing reactive oxygen species: M. Panchatcharam, et al.; Mol. Cell Biochem. 290, 87 (2006), Abstract;
Curcumin inhibits hypoxia-induced angiogenesis via down-regulation of HIF-1: M.K. Bae, et al.; Oncol. Rep. 15, 1557 (2006), Abstract;
Curcumin is an inhibitor of p300 histone acetylatransferase: M.G. Marcu, et al.; Med. Chem. 2, 169 (2006), Abstract;
Curcumin, an atoxic antioxidant and natural NFkappaB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases: S. Bengmark; JPEN J. Parenter. Enteral. Nutr. 30, 45 (2006), (Review), Abstract;
Inhibitory effect of curcumin on nitric oxide production from lipopolysaccharide-activated primary microglia: K.K. Jung, et al.; Life Sci. 79, 2022 (2006), Abstract;
Multiple biological activities of curcumin: a short review: R.K. Maheshwari, et al.; Life Sci. 78, 2081 (2006), (Review), Abstract;
Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells: Z. Wang, et al.; Cancer 106, 2503 (2006), Abstract;
Curcuma longa L. constituents inhibit sortase A and Staphylococcus aureus cell adhesion to fibronectin: B.S. Park, et al.; J. Agric. Food Chem. 53, 9005 (2005), Abstract;
Immunomodulatory effects of curcumin: V.S. Yadav, et al.; Immunopharmacol. Immunotoxicol. 27, 485 (2005), Abstract;
Inhibition of NAD(P)H:quinone oxidoreductase 1 activity and induction of p53 degradation by the natural phenolic compound curcumin: P. Tsvetkov, et al.; PNAS 102, 5535 (2005), Abstract;
Biological properties of curcumin-cellular and molecular mechanisms of action: B. Joe, et al.; Crit. Rev. Food Sci. Nutr. 44, 97 (2004), (Review), Abstract;
Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects: M.E. Egan, et al.; Science 304, 600 (2004), Abstract;
Suppression of nitric oxide oxidation to nitrite by curcumin is due to the sequestration of the reaction intermediate nitrogen dioxide, not nitric oxide: B.D. Johnston & E.G. DeMaster; Nitric Oxide 8, 231 (2003), Abstract;
Effect of curcumin on the production of nitric oxide by cultured rat mammary gland: M. Onoda & H. Inano; Nitric Oxide 4, 505 (2000), Abstract;
In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties: M.M. Chan, et al.; Biochem. Pharmacol. 55, 1955 (1998), Abstract;
Inhibitory effects of curcumin on tumorigenesis in mice: M.T. Huang, et al.; J. Cell. Biochem. (Suppl.) 27, 26 (1997), Abstract;
Nitric oxide scavenging by curcuminoids: Sreejayan & M.N. Rao; J. Pharm. Pharmacol. 49, 105 (1997), Abstract;
Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell lines: M.C. Jiang, et al.; Nutr. Cancer 26, 111 (1996), Abstract;
Curcumin inhibits the proliferation and cell cycle progression of human umbilical vein endothelial cell: A.K. Singh, et al.; Cancer Lett. 107, 109 (1996), Abstract;
Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells: M.L. Kuo, et al.; Biochim. Biophys. Acta 1317, 95 (1996), Abstract;
Cytotoxicity and cytoprotective activities of natural compounds. The case of curcumin: J.N. Commandeur & N.P. Vermeulen; Xenobiotica 26, 667 (1996), Abstract;
Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages: I. Brouet & H. Okshima; BBRC 206, 533 (1995), Abstract;
Inhibitory effect of curcumin on epidermal growth factor receptor kinase activity in A431 cells: L. Korutla & R. Kumar; Biochim. Biophys. Acta 1224, 597 (1994), Abstract;
Inhibition of 5-hydroxy-eicosatetraenoic acid (5-HETE) formation in intact human neutrophils by naturally-occurring diarylheptanoids: inhibitory activities of curcuminoids and yakuchinones: D.L. Flynn, et al.; Prostaglandins Leukot. Med. 22, 357 (1986), Abstract;
Modification of certain inflammation-induced biochemical changes by curcumin: R. Srivastava & R.C. Srimal; Indian J. Med. Res. 81, 215 (1985), Abstract;

Related Literature

Integrated solutions for screening Wnt regulators
Integrated solutions for screening Wnt regulators
Download as PDF

Comprehensive Tools for Quantifying Cellular Responses to Oxidative Damage
Comprehensive Tools for Quantifying Cellular Responses to Oxidative Damage
Download as PDF

All new literature pieces